Koji Takeshita
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Koji Takeshita has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Koichi Takada
3 shared publicationsA Watanabe
Department of Radiology, Teikyo University School of Medicine, Tokyo, Japan
2 shared publicationsHiroshi Kohtake
All authors: Department of Radiology, Teikyo University School of Medicine, 2—11-1, Itabashi-Ku, Tokyo 173—8605, Japan
2 shared publicationsK Kutomi
Department of Radiology, Teikyo University School of Medicine, Tokyo, Japan
2 shared publicationsKimiko Kutomi
2 shared publicationsS Furui
Department of Radiology, Teikyo University School of Medicine, Tokyo, Japan
2 shared publications
Latest Publications
- 1 October 2012
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 85 (1018) , e953-e956
Three-dimensional images of liver tumours reconstructed by Gd-EOB-DTPA-enhanced MRI
The purpose of this study was to evaluate three-dimensional images of liver tumours obtained with gadolinium ethoxybenzyl diethylenetriamine penta-acetic acid (Gd-EOB-DTPA)-enhanced MRI (3D-EOB-MRI) in hepatic surgery. We conclude that 3D-EOB-MRI may be an alternative method for depicting liver tumours adjacent to the hepatic veins and portal branches, and may provide additional information for surgical planning.
- 1 October 2012
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 85 (1018) , e953-e956
Three-dimensional images of liver tumours reconstructed by Gd-EOB-DTPA-enhanced MRI
The purpose of this study was to evaluate three-dimensional images of liver tumours obtained with gadolinium ethoxybenzyl diethylenetriamine penta-acetic acid (Gd-EOB-DTPA)-enhanced MRI (3D-EOB-MRI) in hepatic surgery. We conclude that 3D-EOB-MRI may be an alternative method for depicting liver tumours adjacent to the hepatic veins and portal branches, and may provide additional information for surgical planning.
- 1 October 2010
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 83 (994) , 823-830
Imaging of early pancreatic cancer on multidetector row helical computed tomography
Early pancreatic cancer is small and limited to the pancreas. In contrast, small pancreatic cancer may include peripancreatic vasculature or metastasis involvement. This study evaluates images of early pancreatic cancer on multidetector CT (MDCT) using contrast-enhanced multiphasic imaging, and post-processed pancreatic duct images. CT findings and pathological features were analysed in eight patients with early pancreatic cancer. Pathological evaluation included location, size and histological grading of the tumour. MDCT evaluation covered the maximum diameter of the main pancreatic duct (MPD), stenosis or obstruction of the MPD, loss of normal lobar texture and associated pancreatitis. Attenuation differences between normal pancreatic parenchyma and the tumour (AD–PT) were also measured. Focal stenosis or obstruction of the MPD with dilatation of the distal MPD was demonstrated in all patients. Associated pancreatitis occurred in six patients with tumours measuring 12 mm or greater. Loss of normal lobar...
- 1 October 2010
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 83 (994) , 823-830
Imaging of early pancreatic cancer on multidetector row helical computed tomography
Early pancreatic cancer is small and limited to the pancreas. In contrast, small pancreatic cancer may include peripancreatic vasculature or metastasis involvement. This study evaluates images of early pancreatic cancer on multidetector CT (MDCT) using contrast-enhanced multiphasic imaging, and post-processed pancreatic duct images. CT findings and pathological features were analysed in eight patients with early pancreatic cancer. Pathological evaluation included location, size and histological grading of the tumour. MDCT evaluation covered the maximum diameter of the main pancreatic duct (MPD), stenosis or obstruction of the MPD, loss of normal lobar texture and associated pancreatitis. Attenuation differences between normal pancreatic parenchyma and the tumour (AD–PT) were also measured. Focal stenosis or obstruction of the MPD with dilatation of the distal MPD was demonstrated in all patients. Associated pancreatitis occurred in six patients with tumours measuring 12 mm or greater. Loss of normal lobar...
- 1 March 2008
- Published by Wolters Kluwer Health in Journal of Computer Assisted Tomography
- Vol. 32 (2) , 191-197
Differential Diagnosis of Benign or Malignant Intraductal Papillary Mucinous Neoplasm of the Pancreas by Multidetector Row Helical Computed Tomography
The purpose of this study is to evaluate predictive factors for discriminating benign from malignant intraductal mucin-producing neoplasm (IPMN) of the pancreas on multidetector row computed tomography (MDCT). Fifty-three patients with IPMN underwent MDCT, and the imaging and pathological findings were evaluated. In patients with branch duct-type tumors, sex and age of the patient, location, shape, size and multiplicity of the cystic lesion, presence of mural nodule, and maximum diameter of main pancreatic duct (MPD) dilatation were evaluated by logistic regression analysis. Tumors were classified as main duct-type (n = 7) and branch duct-type (n = 46). Among main duct-type tumors, all 7 lesions were diagnosed as malignant. Among 46 lesions of branch-type IPMN, 8 lesions were malignant, and 38 lesions were benign. On adjusted logistic regression analysis, combination factor of main duct dilatation and mural nodule or large cystic size had statistical significance for the risk of malignancy in branch duct-type IPMN. Main duct-type IPMN is highly suggestive for malignancy. Combination factors of main ductal dilation and mural nodule, and main ductal dilation, and large cystic tumor size are thought to be predictive factors for malignant branch-type IPMN.
- 1 March 2008
- Published by Wolters Kluwer Health in Journal of Computer Assisted Tomography
- Vol. 32 (2) , 191-197
Differential Diagnosis of Benign or Malignant Intraductal Papillary Mucinous Neoplasm of the Pancreas by Multidetector Row Helical Computed Tomography
The purpose of this study is to evaluate predictive factors for discriminating benign from malignant intraductal mucin-producing neoplasm (IPMN) of the pancreas on multidetector row computed tomography (MDCT). Fifty-three patients with IPMN underwent MDCT, and the imaging and pathological findings were evaluated. In patients with branch duct-type tumors, sex and age of the patient, location, shape, size and multiplicity of the cystic lesion, presence of mural nodule, and maximum diameter of main pancreatic duct (MPD) dilatation were evaluated by logistic regression analysis. Tumors were classified as main duct-type (n = 7) and branch duct-type (n = 46). Among main duct-type tumors, all 7 lesions were diagnosed as malignant. Among 46 lesions of branch-type IPMN, 8 lesions were malignant, and 38 lesions were benign. On adjusted logistic regression analysis, combination factor of main duct dilatation and mural nodule or large cystic size had statistical significance for the risk of malignancy in branch duct-type IPMN. Main duct-type IPMN is highly suggestive for malignancy. Combination factors of main ductal dilation and mural nodule, and main ductal dilation, and large cystic tumor size are thought to be predictive factors for malignant branch-type IPMN.
- 7 March 2005
- Published by Springer Nature in Abdominal Radiology
- Vol. 30 (5) , 610-615
Unusual imaging appearances of pancreatic serous cystadenoma: correlation with surgery and pathologic analysis
We describe imaging and pathologic features of serous cystadenoma of the pancreas on multislice helical computed tomography CT (MS-CT) and surgical resection.
- 7 March 2005
- Published by Springer Nature in Abdominal Radiology
- Vol. 30 (5) , 610-615
Unusual imaging appearances of pancreatic serous cystadenoma: correlation with surgery and pathologic analysis
We describe imaging and pathologic features of serous cystadenoma of the pancreas on multislice helical computed tomography CT (MS-CT) and surgical resection.
- 1 March 2005
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 184 (3) , 852-854
3D Pancreatic Arteriography with MDCT During Intraarterial Infusion of Contrast Material in the Detection and Localization of Insulinomas
- 1 March 2005
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 184 (3) , 852-854
3D Pancreatic Arteriography with MDCT During Intraarterial Infusion of Contrast Material in the Detection and Localization of Insulinomas
- 1 May 2002
- Published by Wolters Kluwer Health in Journal of Computer Assisted Tomography
- Vol. 26 (3) , 451-455
Effect of Superparamagnetic Iron Oxide-Enhanced MRI of the Liver With Hepatocellular Carcinoma and Hyperplastic Nodule
To evaluate the possibility of superparamagnetic iron oxide (SPIO)-enhanced magnetic resonance imaging (MRI) of the liver in predicting the histologic grade of hepatocellular carcinoma (HCC) and differentiating HCC from benign hyperplastic nodule (HPN). Thirty patients with 31 histologically proved HCC and HPN underwent MRI (1.5 Tesla). HCCs were graded into well-differentiated HCC (HCCw; n = 10) and moderately to poorly differentiated HCC (HCCmp; n = 15). HPN was categorized into dysplastic nodule (DN; n = 1) and focal nodular hyperplasia (FNH; n = 6). T2-weighted fast spin echo images were obtained before and after administration of SPIO. Signal-to-noise ratios (SNR) of the lesion and surrounding liver parenchyma and contrast-to-noise ratios (CNR) were calculated pre- and postcontrast study. Relative enhancement ratios (RER), also known as signal intensity reduction ratios of the lesions, were also calculated. HCCw, HCCmp, DN, and FNH decreased in SNR after injection of SPIO. RER of HCCw was 19.5 ± 13.3%, that of HCCmp was 6.8 ± 5.8%, DN was 44.0%, and FNH was 42.9 ± 4.8%. Significant statistical differences were seen between HCCw and HCCmp and HCC and HPN in RER. HCCw, HCCmp, and DN increased in CNR, and FNH decreased in CNR, but no lesion showed a statistically significant difference in CNR. SPIO-enhanced MR images may help to predict the histologic grade of HCC and distinguish HCC from HPN.
- 1 May 2002
- Published by Wolters Kluwer Health in Journal of Computer Assisted Tomography
- Vol. 26 (3) , 451-455
Effect of Superparamagnetic Iron Oxide-Enhanced MRI of the Liver With Hepatocellular Carcinoma and Hyperplastic Nodule
To evaluate the possibility of superparamagnetic iron oxide (SPIO)-enhanced magnetic resonance imaging (MRI) of the liver in predicting the histologic grade of hepatocellular carcinoma (HCC) and differentiating HCC from benign hyperplastic nodule (HPN). Thirty patients with 31 histologically proved HCC and HPN underwent MRI (1.5 Tesla). HCCs were graded into well-differentiated HCC (HCCw; n = 10) and moderately to poorly differentiated HCC (HCCmp; n = 15). HPN was categorized into dysplastic nodule (DN; n = 1) and focal nodular hyperplasia (FNH; n = 6). T2-weighted fast spin echo images were obtained before and after administration of SPIO. Signal-to-noise ratios (SNR) of the lesion and surrounding liver parenchyma and contrast-to-noise ratios (CNR) were calculated pre- and postcontrast study. Relative enhancement ratios (RER), also known as signal intensity reduction ratios of the lesions, were also calculated. HCCw, HCCmp, DN, and FNH decreased in SNR after injection of SPIO. RER of HCCw was 19.5 ± 13.3%, that of HCCmp was 6.8 ± 5.8%, DN was 44.0%, and FNH was 42.9 ± 4.8%. Significant statistical differences were seen between HCCw and HCCmp and HCC and HPN in RER. HCCw, HCCmp, and DN increased in CNR, and FNH decreased in CNR, but no lesion showed a statistically significant difference in CNR. SPIO-enhanced MR images may help to predict the histologic grade of HCC and distinguish HCC from HPN.